摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-bromo-4-methylphenoxy)-4,6-dichloro-1,3,5-triazine

中文名称
——
中文别名
——
英文名称
2-(2-bromo-4-methylphenoxy)-4,6-dichloro-1,3,5-triazine
英文别名
——
2-(2-bromo-4-methylphenoxy)-4,6-dichloro-1,3,5-triazine化学式
CAS
——
化学式
C10H6BrCl2N3O
mdl
MFCD17294505
分子量
334.987
InChiKey
DJSVGEBLTUKLFW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    47.9
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(2-bromo-4-methylphenoxy)-4,6-dichloro-1,3,5-triazineN,N-二异丙基乙胺 作用下, 以 1,4-二氧六环异丙醇 为溶剂, 反应 48.0h, 生成 4-((4-amino-6-(2-bromo-4-methylphenoxy)-1,3,5-triazin-2-yl)amino)benzonitrile
    参考文献:
    名称:
    From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds
    摘要:
    The presence of a structural recognition motif for the nucleoside P2 transporter in a library of pyrimidine and triazine non-nucleoside HIV-1 reverse transcriptase inhibitors, prompted for the evaluation of antitrypanosomal activity. It was demonstrated that the structure-activity relationship for anti-HIV and antitrypanosomal activity was different. Optimization in the diaryl triazine series led to 6-(mesityloxy)-N2-phenyl-1,3,5-triazine-2,4-diamine (69), a compound with potent in vitro and moderate in vivo antitrypanosomal activity.
    DOI:
    10.1016/j.bmc.2014.08.005
  • 作为产物:
    描述:
    三聚氯氰2-溴-4-甲基苯酚四丁基硫酸氢铵 、 sodium hydroxide 作用下, 反应 38.0h, 以98%的产率得到2-(2-bromo-4-methylphenoxy)-4,6-dichloro-1,3,5-triazine
    参考文献:
    名称:
    From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds
    摘要:
    The presence of a structural recognition motif for the nucleoside P2 transporter in a library of pyrimidine and triazine non-nucleoside HIV-1 reverse transcriptase inhibitors, prompted for the evaluation of antitrypanosomal activity. It was demonstrated that the structure-activity relationship for anti-HIV and antitrypanosomal activity was different. Optimization in the diaryl triazine series led to 6-(mesityloxy)-N2-phenyl-1,3,5-triazine-2,4-diamine (69), a compound with potent in vitro and moderate in vivo antitrypanosomal activity.
    DOI:
    10.1016/j.bmc.2014.08.005
点击查看最新优质反应信息

文献信息

  • From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds
    作者:Muthusamy Venkatraj、Kevin K. Ariën、Jan Heeres、Jurgen Joossens、Bertrand Dirié、Sophie Lyssens、Johan Michiels、Paul Cos、Paul J. Lewi、Guido Vanham、Louis Maes、Pieter Van der Veken、Koen Augustyns
    DOI:10.1016/j.bmc.2014.08.005
    日期:2014.10
    The presence of a structural recognition motif for the nucleoside P2 transporter in a library of pyrimidine and triazine non-nucleoside HIV-1 reverse transcriptase inhibitors, prompted for the evaluation of antitrypanosomal activity. It was demonstrated that the structure-activity relationship for anti-HIV and antitrypanosomal activity was different. Optimization in the diaryl triazine series led to 6-(mesityloxy)-N2-phenyl-1,3,5-triazine-2,4-diamine (69), a compound with potent in vitro and moderate in vivo antitrypanosomal activity.
查看更多